Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 |
|---|---|---|---|---|---|---|
| 1 | INEBILIZUMAB (Uplizna (TN)) | 1件: Inebilizumab Inebilizumab (Uplizna) | 1件: Inebilizumab
Inebilizumab
(Uplizna (TN)) 💬
| 1件: CD19 CD19 💬
| 5件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | 4件: 11 11, 13, 51, 300 💬
|
| 2 | Uplizna | 1件: Inebilizumab Inebilizumab (Uplizna) | 1件: Inebilizumab
Inebilizumab
(Uplizna (TN)) 💬
| 1件: CD19 CD19 💬
| 5件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | 2件: 11 11, 300 💬
|